Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Antiangiogenesis Role of Histone Deacetylase Inhibitors: Their Potential Application to Tumor Therapy and Tissue Repair
Bin Deng, Qing Luo, Alexander Halim, et al.
DNA and Cell Biology (2019) Vol. 39, Iss. 2, pp. 167-176
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Targeting histone deacetylases for cancer therapy: Trends and challenges
Liang Tao, Fengli Wang, Reham M. Elhassan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2425-2463
Open Access | Times Cited: 86
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
Xiaopeng Peng, Zhiqiang Sun, Peihua Kuang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112831-112831
Closed Access | Times Cited: 92
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies
Chao Ma, Mohammed S. Taghour, Amany Belal, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 59
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 54
Design and biological evaluation of dual tubulin/HDAC inhibitors based on millepachine for treatment of prostate cancer
S Xie, Jiafu Leng, Shifang Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116301-116301
Closed Access | Times Cited: 8
Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency
Yingge Wang, Moran Sun, Yuyang Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113790-113790
Closed Access | Times Cited: 30
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects
Huajian Zhu, Yuchen Tan, Chen He, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 11187-11213
Closed Access | Times Cited: 20
Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles
Raj Shankar Hazra, Debasmita Dutta, Md Rakib Hasan Khan, et al.
ACS Applied Bio Materials (2025)
Closed Access
Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases
Jingjing Wang, Shuyu Feng, Qian Zhang, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 4, pp. 2330-2354
Closed Access | Times Cited: 10
Regenerative properties of bone marrow mesenchymal stem cell derived exosomes in rotator cuff tears
Junjie Chen, Zihe Wang, Ming Yi, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach
Kasturi Ranganna, Chelliah Selvam, Amruthesh C. Shivachar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8198-8198
Open Access | Times Cited: 26
HDAC-an important target for improving tumor radiotherapy resistance
Rui Ling, Jingzhi Wang, Yuan Fang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
A novel dual-epigenetic inhibitor enhances recombinant monoclonal antibody expression in CHO cells
Mingming Han, Hai-Tong Wang, Huijie Zhang, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 2
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1540-1554
Open Access | Times Cited: 15
Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105350-105350
Closed Access | Times Cited: 15
A histone H2A-derived antimicrobial peptide, Hipposin from mangrove whip ray, Himantura walga: Molecular and functional characterisation
P. P. Athira, M.V. Anju, V.V. Anooja, et al.
3 Biotech (2020) Vol. 10, Iss. 11
Open Access | Times Cited: 15
Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy
Athika Darumas Putri, Pai-Shan Chen, Yu-Lin Su, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 13
Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma
Carla Barbaraci, Giovanni Giurdanella, Claudia Giovanna Leotta, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13622-13632
Open Access | Times Cited: 11
Uninterrupted dynamic stiffening microenvironment enhances the paracrine function of mesenchymal stem cells for vascularization through chromatin remodeling
Zhenyin Chen, Yonggang Lv
Materials & Design (2022) Vol. 224, pp. 111328-111328
Open Access | Times Cited: 8
Evaluation of epigenetic (HDAC, DNMT) and pain (Gad65, TGF) factors following photobiomodulation therapy in a neuropathic pain model
Zahra Behroozi, Keihan Kookli, Alireza Ghadaksaz, et al.
Photochemistry and Photobiology (2023)
Closed Access | Times Cited: 3
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluation
Omnia R. Elbatrawy, Moshira A. El Deeb, Mohamed Hagras, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 12, pp. 1019-1035
Closed Access | Times Cited: 3
COX2 Enhances Neovascularization of Inflammatory Tenocytes Through the HIF-1α/VEGFA/PDGFB Pathway
Bin Deng, Pu Xu, Bingyu Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 7
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer
Sofia I. Bär, Alexandra Dittmer, Bianca Nitzsche, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 4
Design and Evaluation of Nanoscale Materials with Programmed Responsivity towards Epigenetic Enzymes
Priyanka Ray, Abbas Sedigh, Matthew Confeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes
Priyanka Ray, Abbas Sedigh, Matthew Confeld, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 39, pp. 9905-9920
Open Access
Page 1 - Next Page

Scroll to top